Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s | ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

Serena Williams says she has lost weight using GLP-1 medication. The drugs help manage blood sugar and promote weight loss, ...

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.

A new Business Group on Health survey finds that nearly a quarter of all employer healthcare spending (24%) went to pharmacy ...

A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...